Identification of a Therapeutic Strategy Targeting Amplified FGF19 in Liver Cancer by Oncogenomic Screening
Top Cited Papers
Open Access
- 1 March 2011
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 19 (3) , 347-358
- https://doi.org/10.1016/j.ccr.2011.01.040
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- The landscape of somatic copy-number alteration across human cancersNature, 2010
- FGF19-induced Hepatocyte Proliferation Is Mediated through FGFR4 ActivationJournal of Biological Chemistry, 2010
- The Right to Choose: Multiple Pathways for Activating Copper,Zinc Superoxide DismutaseJournal of Biological Chemistry, 2009
- Identification of Potential Driver Genes in Human Liver Carcinoma by Genomewide ScreeningCancer Research, 2009
- Focal Gains of VEGFA and Molecular Classification of Hepatocellular CarcinomaCancer Research, 2008
- Roles of Pofut1 and O-Fucose in Mammalian Notch SignalingJournal of Biological Chemistry, 2008
- Oncogene cooperation in tumor maintenance and tumor recurrence in mouse mammary tumors induced by Myc and mutant KrasProceedings of the National Academy of Sciences, 2008
- Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancerProceedings of the National Academy of Sciences, 2007
- Identification and Validation of Oncogenes in Liver Cancer Using an Integrative Oncogenomic ApproachCell, 2006
- Cancer Cell CyclesScience, 1996